Parexel Partners with Ruijin Hospital Hainan Subsidiary to Enhance Real-World Evidence in Drug Development
Parexel, a U.S.-based contract research organization (CRO), has entered into a partnership with Shanghai Ruijin...
CRO / CMO / CDMO
China’s Tigermed Taps Veeva Systems for Advanced Electronic Data Acquisition
Veeva Systems, a U.S.-based life science cloud software specialist, has entered into a partnership with...
Jiuzhou Pharmaceutical Expands Global Footprint with $9.5 Million German CRO Subsidiary
Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA: 603456), a leading Chinese pharmaceutical company, has announced plans...
Porton Pharma Solutions Invests €50 Million in Slovenian R&D Expansion
China-based Contract Development and Manufacturing Organization (CDMO) Porton Pharma Solutions Ltd has inaugurated a new...
Asymchem Laboratories Enters European Market with Pfizer’s UK API Plant and R&D Lab Purchase
Asymchem Laboratories (Tianjin) Co., Ltd (SHE: 002821), a leading China-based Contract Development and Manufacturing Organization...
Pharmaron and AstraZeneca Enter Sweeping Partnership to Span Drug Development Services
Pharmaron Beijing Co., Ltd, a leading Contract Research Organization (CRO) based in Beijing (HKG: 3759;...
Porton Biologics and SAFE Collaborate to Accelerate Pharmaceutical R&D Services
Suzhou Porton Biologics Ltd, a China-based Contract Development and Manufacturing Organization (CDMO), has entered into...
Ribobay Pharma and General Biol to Commence GMP-Grade Oligonucleotide Manufacturing Services
Shanghai-based contract research, development, and manufacturing organization (CRDMO) Ribobay Pharma has announced plans to commence...
BIO Surveys Members on China-CDMO Dependence Amid BioSecurity Bill Deliberations
The Biotechnology Innovation Organization (BIO), a prominent US industry trade group, is conducting a survey...
Bristol-Myers Squibb Prepares Contingency Plans in Response to the Biosecure Act
Bristol-Myers Squibb (BMS; NYSE: BMY), a leading U.S. pharmaceutical company, is reportedly drafting ‘contingency plans’...
Ningbo Menovo Partners with University of Michigan to Develop GLP-1 Delivery System
Ningbo Menovo Pharmaceutical Co., Ltd (SHA: 603538), a China-based company, has announced a strategic partnership...
89bio Partners with BiBio Biopharma to Build API Facility for Pegozafermin in China
U.S. biotechnology company 89bio (NASDAQ: ETNB) has secured the services of China-based Contract Development and...
Boehringer Ingelheim’s Shanghai Unit Secures EMA and FDA Approval for Biopharmaceutical Supply
Germany-based Boehringer Ingelheim has announced that its Shanghai-based Contract Manufacturing Organization (CMO), Boehringer Ingelheim Biopharmaceuticals...
Applied Protein Technology Secures Series C Financing to Accelerate Multi-Omics Innovation
Shanghai-based Applied Protein Technology (APTBIO), a pioneer in life science technology services driven by mass...
US Lawmakers Expand Scrutiny on Chinese Biotech Firms with Potential Military Ties
Despite his announced retirement from Congress effective April 19 this year, Mike Gallagher continues to...
Legend Biotech and Janssen Pharmaceutical Expand Partnership with Novartis for Carvykti Production
Legend Biotech Corporation (NASDAQ: LEGN), a leading Chinese biotech firm, and its U.S. partner Janssen...
Shenzhen Hepalink Reports 2023 Revenue Dip Amid Sector Demand Declines
Shenzhen Hepalink Pharmaceutical Group Co., Ltd (SHE: 002399), a leading pharmaceutical company based in China,...
WuXi AppTec Denies US Allegations of Unauthorized Intellectual Property Transfer
WuXi AppTec (SHA: 603259, HKG: 2359), a leading Contract Research, Development, and Manufacturing Organization (CRDMO)...
FDA Reviews Eisai’s Leqembi for Expanded Use as Monthly Alzheimer’s Therapy
The US Food and Drug Administration (FDA) has given the green light to review an...
Shanghai Medicilon Forms Strategic Partnerships with Binhui Biopharmaceutical and Innoforce Pharmaceuticals
Shanghai Medicilon Biomedical Co., Ltd (SHA: 688202), a prominent Chinese biotech firm, has entered into...